Zoledronic Acid
CZOL446K2418
Approved small_molecule completed
Quick answer
Zoledronic Acid for Paget's Disease of the Bone is a Approved program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Paget's Disease of the Bone
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed